US 11,820,751 B2Granted

Urolithin derivatives and methods of use thereof

AssigneeVandria SA

InventorsChristopher L. Rinsch, Penelope Andreux, Jonathan Mark Sutton, Eileen Mary Seward, Jamie D. Knight, Ian Linney, Peter C. Sennhenn, Said Oumouch, Florent Beaufils, Thomas Christian Fessard

Life of this patent

Estimating the term…

Abstract

Disclosed are compounds, compositions, and methods useful for treating neuronal and mitochondrial diseases.

Claims6

Dependent claims

A compound selected from:

or a pharmaceutically acceptable salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 17/586,294Filed 27 Jan 2022 · us provisional application
Priority: 27 Jan 2021
Published: US 2022/0259173 A118 Aug 2022
Granted: 21 Nov 2023
Term ends: Not estimatedThe source records don’t support an estimate.

Classification18 codes

C07D 223/18
Condensed with carbocyclic rings or ring systems: dibenzazepines; Hydrogenated dibenzazepines
C07D 311/80
Ring systems having three or more relevant rings: dibenzopyrans; Hydrogenated dibenzopyrans
A61P 21/00
Drugs for disorders of the muscular or neuromuscular system
A61P 29/00
Non-central analgesic, antipyretic or antiinflammatory agents

Family

Application63/142,333Us provisional application · filed 27 Jan 2021
US 2022/0259173 A1Pre-grant publication · published 18 Aug 2022
US 11,820,751 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results